Jupiter Topco LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,901,539 shares of the company’s stock, valued at approximately $501,199,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Legal & General Group Plc bought a new position in shares of Merck KGaA in the second quarter worth about $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Merck KGaA during the 2nd quarter valued at about $942,087,000. Canada Pension Plan Investment Board purchased a new stake in Merck KGaA in the 2nd quarter valued at about $536,694,000. Bank of Nova Scotia purchased a new stake in Merck KGaA in the 2nd quarter valued at about $281,696,000. Finally, Danske Bank A S bought a new position in Merck KGaA in the 2nd quarter worth about $276,535,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
Shares of OTCMKTS:MKGAF opened at $164.00 on Wednesday. The firm has a market cap of $21.20 billion, a PE ratio of 25.04 and a beta of 0.96. The firm’s 50 day simple moving average is $163.08 and its 200-day simple moving average is $148.69. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
